Caregen
Financials
Valuation Metrics
Caregen's Market Cap is ₩2.2T. At end of 2025 it was ₩3.9T. Ranked #203 of 2,421 in KR market (top 8%), #39 of 1,640 on KOSDAQ (top 2%), #19 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 8%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 2.15T KRW | KR#203/2,421 Sec#19/231 |
| Revenue | 74.90B KRW | KR#1,582/2,421 Sec#102/231 |
| Net Income | 22.87B KRW | KR#655/2,421 Sec#43/231 |
| Total Assets | 231.27B KRW | KR#1,206/2,421 Sec#86/231 |
| Net Assets | 212.47B KRW | KR#911/2,421 Sec#64/231 |
| Employees | 193 | KR#1,125/2,421 Sec#92/231 |
| Value | ||
| P/E | 94.17x | KR#1,481/2,421 Sec#100/231 |
| P/B | 10.14x | KR#2,356/2,421 Sec#210/231 |
| P/S | 28.76x | KR#2,354/2,421 Sec#189/231 |
| EV/EBITDA | 117.61x | KR#1,507/2,421 Sec#102/231 |
| FCF Yield | 0.68% | KR#1,163/2,421 Sec#85/231 |
| Profitability | ||
| ROE | 10.77% | KR#556/2,421 Sec#37/231 |
| ROA | 9.89% | KR#278/2,421 Sec#22/231 |
| Op. Margin | 24.35% | KR#105/2,421 Sec#14/231 |
| Revenue Growth | -7.63% | KR#1,863/2,421 Sec#175/231 |
| Earnings Growth | -23.73% | KR#947/2,421 Sec#61/231 |
| Financial Health | ||
| Debt Ratio | 8.85% | KR#117/2,421 Sec#24/231 |
| Total Debt | 0 KRW | KR—/2,421 Sec—/231 |
| FCF | 14.73B KRW | KR#608/2,421 Sec#32/231 |
| Cash | 8.86B KRW | KR#1,761/2,421 Sec#155/231 |
| Current Ratio | 7.93x | KR#146/2,421 Sec#30/231 |
| Net Debt/EBITDA | -0.49x | KR#497/2,421 Sec#30/231 |
| Dividend | ||
| Div. Yield | 1.10% | KR#1,093/2,421 Sec#62/231 |
| Div. Growth | -31.72% | KR—/2,421 Sec—/231 |
| Performance | ||
| 1Y Return | -37.73% | KR#1,782/2,421 Sec#146/231 |
| 1M Return | -25.74% | KR#2,341/2,421 Sec#218/231 |
| From 52W High | -73.93% | KR#2,269/2,421 Sec#197/231 |
| 1Y MDD | -73.28% | KR#2,121/2,421 Sec#187/231 |
| Trading | ||
| Volume | 50,007 shares | KR#1,132/2,421 Sec#112/231 |
| Trading Value | 2.01B KRW | KR#556/2,421 Sec#54/231 |
| Foreign Own. | 4.68% | KR#915/2,421 Sec#81/231 |
| Per Share | ||
| EPS | 426 KRW | KR#1,055/2,421 Sec#74/231 |
| BPS | 3,956 KRW | KR#1,680/2,421 Sec#123/231 |
Company Info
Caregen, established in 2001 and listed on KOSDAQ in 2015, is a biotechnology company headquartered in Gangnam-gu, Seoul. It researches and develops peptides and growth factor proteins, selling professional therapy products, functional cosmetics, and health functional foods in 130 countries. The company has built a peptide library with 833 domestic and international patent registrations and is developing new drug pipelines for conditions like macular degeneration, diabetes, and hair loss. Caregen is also expanding its business into new areas such as specialized animal pharmaceuticals and functional feeds.